Decreased serum phosphate levels after high-dose estrogens in metastatic prostate cancer
- 1 May 1984
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 76 (5) , 787-793
- https://doi.org/10.1016/0002-9343(84)90987-2
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Chemohormonal therapy of metastatic prostate cancer. A pilot studyCancer, 1983
- A phase II evaluation of adriamycin and cis-platinum in hormone resistant prostate cancerCancer, 1982
- Hypophosphatemic Osteomalacia: Association with Prostatic CarcinomaAnnals of Internal Medicine, 1980
- The Vitamin D Hormonal System: Implications for Bone DiseasesHospital Practice, 1980
- The Pathophysiology and Clinical Characteristics of Severe HypophosphatemiaArchives of internal medicine (1960), 1977
- Suppression of Plasma Androgens by Spironolactone in Castrated Men with Carcinoma of the ProstateJournal of Urology, 1975
- The veterans administration cooperative urological research group's studies of cancer of the prostateCancer, 1973
- Experience in the Treatment of Prostatic Carcinoma with Cyproterone AcetateJournal of Urology, 1973
- Urinary Total Hydroxyproline, Calcium and Phosphorus Excretion after Administration of Calcium and Oestrogen to Postmenopausal WomenPharmacology, 1972
- Hypocalcemia and Hypophosphatemia Accompanying Osteoblastic Osseous Metastases: Studies of Calcium and Phosphate Metabolism and Parathyroid Function.Annals of Internal Medicine, 1962